Genpact (NYSE:G) Stock: Insider Piyush Mehta Sells 200,000 Shares

Genpact Limited (NYSE:G) SVP Piyush Mehta sold 200,000 shares of Genpact stock in a transaction on Tuesday, November 10th. The shares were sold at an average price of $43.05, for a total transaction of $8,610,000.00. Following the completion of the sale, the senior vice president owned 156,823 shares of the company’s stock, valued at $6,751,230.15. This represents a 56.05% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Genpact Stock Up 1.2%

Shares of Genpact stock traded up $0.54 during trading on Friday, reaching $43.67. 2,444,134 shares of the company traded hands, compared to its average volume of 2,083,718. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.95 and a quick ratio of 2.00. Genpact Limited has a 1-year low of $26.85 and a 1-year high of $48.64. The company has a 50 day moving average price of $37.07 and a 200-day moving average price of $35.47. The firm has a market capitalization of $7.30 billion, a PE ratio of 12.73, a P/E/G ratio of 1.12 and a beta of 0.53.

Genpact (NYSE:G) last issued its earnings results on Thursday, November 5th. The business services provider reported $1.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.04 by $0.03. Genpact had a net margin of 11.04% and a return on equity of 23.02%. The business’s revenue was up 7.3% compared to the same quarter last year. During the same quarter last year, the firm earned $0.97 EPS. As a group, equities research analysts expect that Genpact Limited will post 3.66 earnings per share for the current fiscal year.

Genpact Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 23rd. Stockholders of record on Thursday, December 10th will be issued a dividend of $0.1875 per share. The ex-dividend date is Thursday, December 10th. This represents a $0.75 annualized dividend and a dividend yield of 1.7%. Genpact’s dividend payout ratio is currently 21.87%.

Institutional Investors Weigh In On Genpact

A number of institutional investors and hedge funds have recently bought and sold shares of G. Pension & Wealth Management Advisors Inc. bought a new stake in shares of Genpact in the 3rd quarter worth $27,000. Root Financial Partners LLC bought a new position in shares of Genpact during the third quarter valued at about $30,000. Basecamp Wealth Advisors LLC lifted its position in shares of Genpact by 54.7% during the first quarter. Basecamp Wealth Advisors LLC now owns 1,046 shares of the business services provider’s stock valued at $39,000 after purchasing an additional 370 shares in the last quarter. Elevation Wealth Partners LLC lifted its position in shares of Genpact by 57.2% during the third quarter. Elevation Wealth Partners LLC now owns 1,339 shares of the business services provider’s stock valued at $44,000 after purchasing an additional 487 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. purchased a new position in Genpact during the third quarter worth about $77,000. 96.03% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the company. Needham & Company LLC raised their target price on Genpact from $45.00 to $55.00 and gave the company a “buy” rating in a research note on Friday, November 6th. JPMorgan Chase & Co. increased their price target on Genpact from $40.00 to $45.00 and gave the stock a “neutral” rating in a report on Friday, August 7th. Susquehanna raised their price objective on Genpact from $40.00 to $42.00 and gave the company a “neutral” rating in a research note on Friday, November 6th. Citigroup raised their price objective on Genpact from $36.00 to $44.00 and gave the company a “neutral” rating in a research note on Monday, November 9th. Finally, Wall Street Zen downgraded Genpact from a “buy” rating to a “hold” rating in a report on Saturday, November 7th. Two research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Genpact currently has an average rating of “Hold” and an average price target of $41.89.

Key Genpact News

Here’s some of the latest news about G:

• Positive Sentiment: Mars has opened a global capability center in Hyderabad in collaboration with Genpact and plans to grow the workforce there to 1,000. The project points to continued client demand and potential for expanded services. Mars opens GCC in Hyderabad with Genpact, plans to scale workforce to 1,000
• Neutral Sentiment: Genpact’s new survey found that while 79% of enterprises have AI agents in production, only 15% have tied AI investment to profit-and-loss outcomes. This highlights a significant opportunity for Genpact’s operations expertise, but also shows that converting AI adoption into measurable business value remains a challenge. Genpact report on AI agents and business value
• Negative Sentiment: Senior Vice President Piyush Mehta sold 200,000 shares for about $8.61 million, cutting his direct holdings by 56.05%. The large insider sale could raise concerns, although it does not by itself indicate a change in the company’s outlook. SEC filing for Piyush Mehta share sale

Genpact Company Profile

Genpact is a global professional services company that helps businesses improve operations and pursue digital transformation. Its services include business process management, consulting, data and analytics, artificial intelligence, and technology implementation. The company works with clients across industries such as banking and financial services, insurance, consumer goods, healthcare, life sciences, manufacturing, and technology. It serves organizations around the world through its global operations.